Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    GALE

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/01/2016 02/02/2016 02/03/2016 02/04/2016 02/05/2016 Date
0.65(c) 0.6207(c) 0.6414(c) 0.6601(c) 0.6301(c) Last
2 354 910 1 285 011 1 505 466 976 332 1 137 072 Volume
-2.99% -4.51% +3.33% +2.92% -4.54% Change
More quotes
Financials ($)
Sales 2015 9,41 M
EBIT 2015 -41,1 M
Net income 2015 -46,6 M
Debt 2015 -
Yield 2015 -
Sales 2016 8,76 M
EBIT 2016 -42,9 M
Net income 2016 -43,6 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 12,2x
Capi. / Sales 2016 13,1x
Capitalization 114 M
More Financials
Company
Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.Its development portfolio ranges from mid to late stage clinical assets which include... 
Sector
Pharmaceuticals
Calendar
02/08 | 11:30amPresentation
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GALENA BIOPHARMA INC
02/02 Galena Biopharma to Present at the BIO CEO & Investor Conference
01/21 Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients..
01/13 Galena Biopharma Provides 2016 Outlook
01/12 GALENA BIOPHARMA : to Present at NobleCon12 - Noble Financial Capital Markets Tw..
01/11 Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets&r..
01/07 GALENA BIOPHARMA : Entry into a Material Definitive Agreement (form 8-K)
01/07 GALENA BIOPHARMA : Entry into a Material Definitive Agreement, Other Events, Fin..
01/07 Galena Biopharma Announces Pricing of Public Offering of Common Stock and War..
More news
Sector news : Pharmaceuticals - NEC
06:01pDJDrug Industry Launches Ad Campaign Aimed at Lawmakers
02/06 PFIZER : Groton's 2015 grand list declines .8 percent
02/05 SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
01/27 NEUVAX VACCINE : A Matter Of Signal Integrity (Part 2)
01/14 NEUVAX VACCINE : A Matter Of Signal Integrity
01/07 Midday Gainers / Losers
01/07 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
01/06 Galena initiates equity offering; shares slump 12% after hours


Comments 
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions